- Home
- BEAT vs CRT Comparison
BEAT vs CRT Comparison
Compare BEAT & CRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAT
- CRT
- Stock Information
- Founded
- BEAT 2015
- CRT 1991
- Country
- BEAT United States
- CRT United States
- Employees
- BEAT N/A
- CRT N/A
- Industry
- BEAT Retail: Computer Software & Peripheral Equipment
- CRT Oil & Gas Production
- Sector
- BEAT Technology
- CRT Energy
- Exchange
- BEAT Nasdaq
- CRT Nasdaq
- Market Cap
- BEAT 65.4M
- CRT 64.0M
- IPO Year
- BEAT 2021
- CRT 1992
- Fundamental
- Price
- BEAT $2.00
- CRT $12.26
- Analyst Decision
- BEAT Buy
- CRT
- Analyst Count
- BEAT 1
- CRT 0
- Target Price
- BEAT $8.00
- CRT N/A
- AVG Volume (30 Days)
- BEAT 57.4K
- CRT 33.6K
- Earning Date
- BEAT 03-13-2025
- CRT 01-01-0001
- Dividend Yield
- BEAT N/A
- CRT 8.11%
- EPS Growth
- BEAT N/A
- CRT N/A
- EPS
- BEAT N/A
- CRT 0.95
- Revenue
- BEAT N/A
- CRT $6,623,430.00
- Revenue This Year
- BEAT N/A
- CRT N/A
- Revenue Next Year
- BEAT N/A
- CRT N/A
- P/E Ratio
- BEAT N/A
- CRT $13.92
- Revenue Growth
- BEAT N/A
- CRT N/A
- 52 Week Low
- BEAT $1.70
- CRT $8.88
- 52 Week High
- BEAT $3.48
- CRT $14.98
- Technical
- Relative Strength Index (RSI)
- BEAT 46.64
- CRT 61.40
- Support Level
- BEAT $1.85
- CRT $11.60
- Resistance Level
- BEAT $2.03
- CRT $12.43
- Average True Range (ATR)
- BEAT 0.11
- CRT 0.52
- MACD
- BEAT 0.00
- CRT 0.15
- Stochastic Oscillator
- BEAT 51.35
- CRT 61.91
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About CRT Cross Timbers Royalty Trust
Cross Timbers Royalty Trust is a United States based trust. Its principal asset is the net profits interests. The net profits interests are derived from producing royalty, overriding royalty interests, and working interests properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.